Conclusions
Higher concentrations of TA were needed to inhibit chemiluminescence than LTB4 formation (whereas indomethacin and timegadine reduced these two phenomena with similar potencies) suggesting a specific blockade of 5-lipoxygenase by TA. Oral TA decreased leukotriene production in PMNsex vivo. This may be related to the good anti-inflammatory and anti-migraine actions of TA, and partly explain its rare gastric and bronchoconstrictive adverse effects. However, the recommended single oral dose (100–400 mg) seems to be too low to decrease systemic LT-synthesis in all subjects.
Similar content being viewed by others
References
R. Fruchtmann, U. Krupka und B. Pelster,Hemmung des Lipoxygenase- und Cyclooxygenaseweges im Arachidonsäure-Metabolismus durch Etofenamat. Akt Rheumatol9, 165–168 (1984).
A. M. Boctor, M. Eickholt and T. A. Pugsley,Meclofenamate sodium is an inhibitor of both the 5-lipoxygenase and cyclooxygenase pathways of the arachidonic acid cascade in vitro. Prostaglandins Leukotrienes Med23, 229–238 (1986).
E. Moilanen, J. Alanko, E. Seppälä and H. Vapaatalo,Effects of antirheumatic drugs on leukotriene B 4 and prostanoid synthesis in human polymorphonuclear leukocytes in vitro. Agents and Actions24, 387–394 (1988).
F. J. Zijlstra and J. E. Vincent,Determination of leukotrienes and prostaglandins in (14 C)-arachidonic acid labelled human lung tissue by high-performance liquid chromatography and radioimmunoassay. J Chromatogr311, 39–50 (1984).
E. Seppälä, O. Pora and T. Metsä-Ketelä,A modified method for extraction and purification of prostaglandins with resin XAD-2. Prostaglandins Leukotrienes Med14, 235–241 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Alanko, J., Moilanen, E., Opas, J. et al. Tolfenamic acid inhibits leukotriene synthesis in human granulocytes. Agents and Actions 26, 254–255 (1989). https://doi.org/10.1007/BF02126630
Issue Date:
DOI: https://doi.org/10.1007/BF02126630